Bank of America’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-8,500
Closed -$3.72M – 8097
2023
Q3
$3.72M Buy
+8,500
New +$4.24M ﹤0.01% 3675
2016
Q3
– Sell
-6,000
Closed -$557K – 7215
2016
Q2
$557K Hold
6,000
– – ﹤0.01% 4588
2016
Q1
$470K Buy
+6,000
New +$432K ﹤0.01% 4642

Other funds holding IDXX

Bank of America's IDXX Position: Q2 2026 in Review

Bank of America reduced its Idexx Laboratories (IDXX) stake by 2.3% in Q2 2026, selling an estimated $6.18M and leaving 476,998 shares worth $251M. The position accounts for 0.02% of the portfolio, ranked #682.

Bank of America first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $799M in Q3 2021. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Bank of America held 476,998 shares of Idexx Laboratories worth $251M as of Q2 2026.
  • Bank of America sold 11,019 Idexx Laboratories shares in Q2 2026, an estimated $6.18M.
  • Idexx Laboratories made up 0.02% of Bank of America's portfolio in Q2 2026, its #682 holding.
  • Bank of America first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Bank of America's Idexx Laboratories position peaked at $799M in Q3 2021.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.